Page 135 - ICD-AR22-English

Notes to the Separate Financial Statements
FOR THE YEAR ENDED 31 DECEMBER 2022
An analysis of changes in ECL allowances in relation to Corporation’s financial assets were as follows:
Description
31 December 2022
Stage 1 USD
Stage 2 USD
Stage 3 USD
Total USD
Provisions as at 1 January 2022 8,148,636
New assets originated or purchased 5,843,068 Assets repaid (45,797) Transfer from stage 1 to Stage 2 (5,675) Transfer from stage 3 to Stage 2 - Transfer from stage 3 to Stage 1 252,598 Increase/decrease provision 281,514
9,238,244
1,969,998 (321,789) 57,681 936,860
(3,195,622)
118,325,729
-
(11,088,829)
-
(12,327,519)
(557,956)
12,306,114
135,712,609
7,813,066
(11,456,415)
52,006
(11,390,659)
(305,358)
9,392,006
14,474,344
8,685,372
106,657,539
129,817,255
Equity investments
12,232,623
Provisions as at 31 December 2022
142,049,878
Description
31 December 2021
Stage 1 USD
Stage 2 USD
Stage 3 USD
Total USD
Provisions as at 1 Jan 2021 7,455,634
New assets originated or purchased 3,760,876 Assets repaid (1,614,078) Writeoffs - Transfer from stage 1 to Stage 2 (1,389,022) Transfer from stage 2 to Stage 3 - Transfer from stage 2 to Stage 1 198,391 Transfer from stage 3 to Stage 1 28,069 New and increased provision (net of releases) (291,234)
9,210,635
292,959 (1,631,484) - 6,054,845 - (1,173,811) - (3,514,900)
123,160,974
-
(59,704)
-
-
-
-
(497,060)
(4,278,481)
139,827,243
4,053,835
(3,305,266)
0
4,665,823
0
(975,420)
(468,991)
(8,084,615)
Provisions as at 31 December 2021
8,148,636
9,238,244
118,325,729
135,712,609
REINVIGORATING THE PRIVATE SECTOR TO SHAPE A BETTER FUTURE 133